Found 31 matching trials
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation
PHASE2The relapse of acute leukemia, MDS and blast phase CML after allogeneic tra...
Location
Emory University Winship Cancer Institute
Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B
EARLY_PHASE1Previous studies have shown that there are alterations in the number and af...
Location
The First Affiliated Hospital of Anhui Medical University
A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
PHASE2This is a randomized, open-label, multicenter phase II study to evaluate th...
Location
Beijing Friendship Hospital, Capital Medical University
Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation
PHASE2Evaluation of efficacy of triple therapy with pegylated interferon, ribavir...
Location
Haut-Lévêque Hospital
Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL
NARATIONALE: PEG-interferon alfa-2b may interfere with the growth of cancer c...
Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis Patients
PHASE2The study aims to demonstrate that whether treatment of nucleoside (acid)an...
Location
Third Affliated Hospital of Sun Yat-sen University
Pilot Study of IFN α2b for Melanoma Patients
EARLY_PHASE1The presence of malignant cells in lymph nodes is a critical parameter in t...
Location
UPMC Hillman Cancer Center
Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis
PHASE2To study the efficacy and safety of combination of Ro-Peg-interferon-α2b (R...
Location
Aalborg university hospital
Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC)
PHASE3The cohort of post-menopausal women represents a group of very-difficult-to...
Location
Gastroenterology Unit
36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8
PHASE4Purpose:
To compare the effectiveness of 36 weeks versus 48 weeks pegintro...
Location
Kaohsiung Veterans General Hospital